1st Quarter - Report
AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2024 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON | — |
| MATTHEW GONTARCHICK New | — |
| MARC JOHNSON | — |
Medical/Disease Research/Clinical Labs MED
Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, and prevention
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MATTHEW GONTARCHICK New | — |
| MARC JOHNSON | — |
Tobacco TOB
Tobacco control and prevention Tobacco cessation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MATTHEW GONTARCHICK New | — |
| MARC JOHNSON | — |
Health Issues HCR
Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANA MILLER ACTON New | — |
| MATTHEW GONTARCHICK New | — |
| MARC JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.